News

Featured News

  • 2022 |
  • 2021 |
  • 2020 |
  • 2019 |
  • 2018 |
  • 2017 |
  • View All
  • News | November 14, 2022

    Ionis, Metagenomi pen Big Pharma-sized genetic target pact that could total almost $3B

    Read More

    Press Release | November 7, 2022

    Zenas BioPharma Secures $118 Million to Advance Its Broad Pipeline of Autoimmune Disease Therapeutics

    Read More

    Press Release | October 11, 2022

    DICE Therapeutics Announces Positive Topline Data from Phase 1 Clinical Trial of Lead Oral IL-17 Antagonist, DC-806, for Psoriasis

    Read More

    Press Release | October 3, 2022

    Metagenomi Announces Opening of Manufacturing Facility for its Next Generation CRISPR Gene-Editing Systems and Therapies

    Read More